UROTEST GPH

Atomic Absorption, Lithium

IN WHA PHARMACEUTICAL CO., LTD.

The following data is part of a premarket notification filed by In Wha Pharmaceutical Co., Ltd. with the FDA for Urotest Gph.

Pre-market Notification Details

Device IDK912244
510k NumberK912244
Device Name:UROTEST GPH
ClassificationAtomic Absorption, Lithium
Applicant IN WHA PHARMACEUTICAL CO., LTD. BUK-KU CHUNGCHUN-DONG 234-1 Korea,  KR
Product CodeJII  
CFR Regulation Number862.3560 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1991-05-21
Decision Date1991-11-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.